Variant report
Variant | esv3521898 |
---|---|
Chromosome Location | chr6:29763303-29763531 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs78960639 | chr6:29763303-29763304 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs9258407 | chr6:29763307-29763308 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs13437595 | chr6:29763308-29763309 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs9258408 | chr6:29763311-29763312 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs201683757 | chr6:29763315-29763316 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs58553945 | chr6:29763316-29763317 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
7 | rs572637121 | chr6:29763318-29763319 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs9258410 | chr6:29763320-29763321 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
9 | rs9258411 | chr6:29763324-29763325 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs9258412 | chr6:29763328-29763329 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs9258413 | chr6:29763332-29763333 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs9258414 | chr6:29763336-29763337 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs9258415 | chr6:29763340-29763341 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs9258416 | chr6:29763344-29763345 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs9258417 | chr6:29763348-29763349 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs9258418 | chr6:29763352-29763353 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs9258419 | chr6:29763356-29763357 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
18 | rs9258420 | chr6:29763360-29763361 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs540841151 | chr6:29763364-29763365 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs189795868 | chr6:29763365-29763366 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs376962816 | chr6:29763367-29763368 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs9258421 | chr6:29763368-29763369 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs185057775 | chr6:29763372-29763373 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs191040145 | chr6:29763375-29763376 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs546856689 | chr6:29763376-29763377 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs9258422 | chr6:29763389-29763390 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs566693858 | chr6:29763391-29763392 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs544562045 | chr6:29763393-29763394 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs58686029 | chr6:29763403-29763404 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs370134018 | chr6:29763421-29763422 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs539020039 | chr6:29763480-29763481 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs563224619 | chr6:29763496-29763497 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs374513563 | chr6:29763503-29763504 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs9258423 | chr6:29763510-29763511 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs578105416 | chr6:29763515-29763516 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs545654678 | chr6:29763516-29763517 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs9258427 | chr6:29763526-29763527 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs9258428 | chr6:29763530-29763531 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 19571809 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21509527 | CNVD |
Melanoma | 17363583 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:29760400-29764400 | Weak transcription | Hela-S3 | cervix |
2 | chr6:29761000-29765200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr6:29761200-29763800 | Weak transcription | HMEC | breast |
4 | chr6:29761200-29763800 | Weak transcription | NHEK | skin |
5 | chr6:29761200-29764400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
6 | chr6:29761400-29763800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
7 | chr6:29761800-29766200 | Weak transcription | Pancreas | Pancrea |
8 | chr6:29762200-29764600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
9 | chr6:29763000-29763800 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |